Ernie De Paolantonio
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ernie De Paolantonio
Earlier roles on record: CFO at Journey Medical Corp (DERM) until January 27, 2023. Journey Medical Corp reported in an 8-K filed January 20, 2023 that Ernie De Paolantonio resigned as Chief Financial Officer, effective January 27, 2023. The proxy statement of Journey Medical Corp reports total compensation of $32,962 for Ernie De Paolantonio in fiscal 2023, including a base salary of $31,693. Disclosed compensation is on record for 3 fiscal years. Ernie De Paolantonio has spoken on 3 earnings calls across 1 company, most recently for Journey Medical Corp on November 10, 2022.
“On January 16, 2023, Ernest De Paolantonio, the Chief Financial Officer of Journey Medical Corporation (the "Company") provided notice to the Company of his resignation, effective January 27, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-01-27
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Journey Medical Corp (DERM) | Former Chief Financial Officer | $31,693 | $32,962 |
| 2022 | Journey Medical Corp (DERM) | Former Chief Financial Officer | $306,800 | $1,458,700 |
| 2021 | Journey Medical Corp (DERM) | Chief Financial Officer | $76,367 | $150,368 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.